Angelucci, E. Et Al. 2005. Iron chelation therapy with deferasirox (Exjade (R), ICL670) or deferoxamine is effective in reducing iron overload in patients with advanced fibrosis and cirrhosis.. 47th Annual Meeting of the American-Society-of-Hematology , (Georgia, United States Of America).

Angelucci, E., Turlin, B., Canatan, D., Mangiagli, A., De Sanctis, V., Meddeb, B., ... Rose, C.(2005). Iron chelation therapy with deferasirox (Exjade (R), ICL670) or deferoxamine is effective in reducing iron overload in patients with advanced fibrosis and cirrhosis. . 47th Annual Meeting of the American-Society-of-Hematology, Georgia, United States Of America

Angelucci, E Et Al. "Iron chelation therapy with deferasirox (Exjade (R), ICL670) or deferoxamine is effective in reducing iron overload in patients with advanced fibrosis and cirrhosis.," 47th Annual Meeting of the American-Society-of-Hematology, Georgia, United States Of America, 2005

Angelucci, E Et Al. "Iron chelation therapy with deferasirox (Exjade (R), ICL670) or deferoxamine is effective in reducing iron overload in patients with advanced fibrosis and cirrhosis.." 47th Annual Meeting of the American-Society-of-Hematology , Georgia, United States Of America, 2005

Angelucci, E. Et Al. (2005) . "Iron chelation therapy with deferasirox (Exjade (R), ICL670) or deferoxamine is effective in reducing iron overload in patients with advanced fibrosis and cirrhosis.." 47th Annual Meeting of the American-Society-of-Hematology , Georgia, United States Of America.

@conferencepaper{conferencepaper, author={E Angelucci Et Al. }, title={Iron chelation therapy with deferasirox (Exjade (R), ICL670) or deferoxamine is effective in reducing iron overload in patients with advanced fibrosis and cirrhosis.}, congress name={47th Annual Meeting of the American-Society-of-Hematology}, city={Georgia}, country={United States Of America}, year={2005}}